glp-1 and ulcerative colitis Frontiers The alleviating effect and mechanism
Description
Incretin-based therapies for type 2 diabetes mellitus
Anti-exenatide antibodies were detected in 40%-60% of clinical patients
It is time to stop struggling
Traditionally available only as injections, GLP1 receptor agonists have shown impressive results in lowering blood glucose, aiding in weight loss, and protecting the heart
59 TrujilloJ
By helping patients lose weight, Wegovy can also lower the risk of cardiovascular events like heart attack or heart disease
